INTERACTIONS STUDY OF THE LOW-MOLECULAR-WEIGHT HEPARINOID ORG-10172 (LOMOPARAN) AND ACETYLSALICYLIC-ACID IN HEALTHY MALE-VOLUNTEERS

被引:0
|
作者
DEBOER, A
DANHOF, M
COHEN, AF
MAGNANI, HN
BREIMER, DD
机构
[1] CTR HUMAN DRUG RES,2300 RC LEIDEN,NETHERLANDS
[2] LEIDEN STATE UNIV,CTR BIOPHARMACEUT SCI,DIV PHARMACOL,2312 AV LEIDEN,NETHERLANDS
[3] ORGANON INT BV,OSS,NETHERLANDS
关键词
D O I
10.1016/0014-2999(90)93567-A
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:641 / 641
页数:1
相关论文
共 39 条
  • [21] SYNOPSIS OF THE ANTICOAGULANT AND ANTITHROMBOTIC PROFILE OF THE LOW-MOLECULAR WEIGHT HEPARINOID ORG-10172 IN EXPERIMENTAL-MODELS
    MEULEMAN, DG
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1989, 15 (04): : 370 - 372
  • [22] ORG 10172 - A LOW-MOLECULAR-WEIGHT HEPARINOID ANTICOAGULANT WITH A LONG HALF-LIFE IN MAN
    BRADBROOK, ID
    MAGNANI, HN
    MOELKER, HCT
    MORRISON, PJ
    ROBINSON, J
    ROGERS, HJ
    SPECTOR, RG
    VANDINTHER, T
    WIJNAND, H
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 23 (06) : 667 - 675
  • [23] DOUBLE-BLIND RANDOMIZED TRIAL OF ORG-10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE
    TURPIE, AGG
    HIRSH, J
    JAY, RM
    ANDREW, M
    HULL, RD
    LEVINE, MN
    CARTER, CJ
    POWERS, PJ
    MAGNANI, HN
    GENT, M
    LANCET, 1987, 1 (8532): : 523 - 526
  • [24] A DOUBLE-BLIND RANDOMIZED TRIAL OF ORG-10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN THE PREVENTION OF DEEP-VEIN THROMBOSIS IN PATIENTS WITH THROMBOTIC STROKE
    TURPIE, AGG
    LEVINE, MN
    HIRSH, J
    CARTER, CJ
    JAY, RM
    POWERS, PJ
    ANDREW, M
    MAGNANI, HN
    HULL, RD
    GENT, M
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 123 - 123
  • [25] FIBRINOLYTIC COMPLEXES OF LOW-MOLECULAR-WEIGHT HEPARIN WITH ACETYLSALICYLIC-ACID
    KUDRYASHOV, BA
    PASTOROVA, VE
    LYAPINA, LA
    KONDRASHEVSKAYA, MV
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1992, 114 (08) : 1100 - 1102
  • [26] THE USE OF A LOW-MOLECULAR-WEIGHT HEPARINOID (ORG 10172) FOR EXTRACORPOREAL PROCEDURES IN PATIENTS WITH HEPARIN DEPENDENT THROMBOCYTOPENIA AND THROMBOSIS
    ROWLINGS, PA
    MANSBERG, R
    ROZENBERG, MC
    EVANS, S
    MURRAY, B
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1991, 21 (01): : 52 - 54
  • [27] TIME COURSES OF THE ANTITHROMBOTIC EFFECTS, BLEEDING ENHANCING EFFECTS AND INTERACTIONS WITH FACTORS-XA AND THROMBIN AFTER ADMINISTRATION OF LOW-MOLECULAR WEIGHT HEPARINOID ORG-10172 OR HEPARIN TO RATS
    HOBBELEN, PMJ
    VOGEL, GMT
    MEULEMAN, DG
    THROMBOSIS RESEARCH, 1987, 48 (05) : 549 - 558
  • [28] HEPARIN-ASSOCIATED THROMBOCYTOPENIA TYPE-II IN A PATIENT WITH END-STAGE RENAL-DISEASE - SUCCESSFUL ANTICOAGULATION WITH THE LOW-MOLECULAR-WEIGHT HEPARINOID ORG-10172 DURING HEMODIALYSIS
    GREINACHER, A
    PHILIPPEN, KH
    KEMKESMATTHES, B
    MOCKL, M
    MUELLERECKHARDT, C
    SCHAEFER, K
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (10) : 1176 - 1177
  • [29] THE EFFECT OF ACETYLSALICYLIC-ACID IN 3 DIFFERENT FORMULATIONS ON INVITRO AND INVIVO PLATELET-FUNCTION TESTS - AN EXPERIMENTAL-STUDY ON HEALTHY MALE-VOLUNTEERS
    KUTTI, J
    SAFAIKUTTI, S
    SIGVALDASON, A
    EDGAR, B
    LUNDBORG, P
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1984, 32 (04): : 379 - 384
  • [30] HEPARIN-INDUCED THROMBOCYTOPENIA TYPE-II - PLATELET-AGGREGATION STUDIES WITH LOW-MOLECULAR-WEIGHT HEPARINS AND HEPARINOID ORG 10172
    HARBRECHT, UM
    UNKRIG, CJ
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 1302 - 1302